Clinical Trial

Retrolaminar Block Analgesia and Patient Comfort During Prone ESWL

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 17, 2025 (before its estimated November 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this prospective, observational study is to evaluate the effect of retrolaminar block (RLB) on patient comfort and analgesic effectiveness during extracorporeal shock wave lithotripsy (ESWL) procedures. The main questions the study aims to answer are: Does retrolaminar block reduce pain intensity during ESWL? Does retrolaminar block improve patient comfort during ESWL? Participants will undergo the following interventions: RLB Group: Retrolaminar block performed under ultrasound guidance prior to ESWL. Sedation Group (S): Standard sedoanalgesia administered. Control Group (C): No additional regional block or sedoanalgesia applied. Participants will be monitored for pain levels, procedural duration, hemodynamic parameters, and the need for additional analgesics. The study aims to determine whether retrolaminar block can serve as a safe and effective analgesic method during ESWL procedures.
Trial Details
NCT Number NCT07177625
Lead Sponsor Elazıg Fethi Sekin Sehir Hastanesi
Conditions Urolithiasis
Enrollment 90 participants
Start Date 2025-09-15
Primary Completion 2025-11-15 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-17